Skip to content

Utility of ultrasound scan as a predictor of life threatening bleeding in patients with liver disease

A prospective study on utilising shear wave elastography as a predictor of oesophageal varices in patients with cirrhosis of liver

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047479
Enrollment
99
Registered
2022-11-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K740- Hepatic fibrosis

Interventions

Intervention1: Shear wave elastography: Using the LOGIQ S8 R3.1.9 software and the C1-6-D probe non invasively to check for liver stiffness. This will be checked in 99 patients over a period of 12 mo

Sponsors

Father Muller Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Men and women aged between 30 to 65 years who are diagnosed to have chronic liver disease based on supporting history and laboratory parameters. 2.History of significant alcohol consumption as defined by more than 21 units and 14 units of alcohol per week for males and females respectively. 3.Time interval between SWE and OGD 4.No history of consumption of beta blockers 5.No known prior liver insult â?? Infections, recreational drugs, autoimmunity, etc. 6.No previous history of upper gastrointestinal haemorrhage in the past

Exclusion criteria

Exclusion criteria: 1.Non alcoholic causes of liver cirrhosis. (Viral, toxins, extra-hepatic porto-venous obstruction and childhood history of paediatric cirrhosis) 2.Patients with ultrasongraphy findings of fatty liver 3.Patients with significant alcohol consumption who have alcoholic liver diseases in the stage of steato-hepatitis. 4.Patient on treatment with hepatotoxic drugs for an unrelated condition 5.Prior diagnosis of portal hypertension, oesophageal varices, hepatocelluar carcinoma, hepatic encephalopathy, portal vein thrombosis and liver trauma 6.Concomitant comorbidities such as heart failure â?? NYHA III and IV, acute asthma attack, recent myocardial infarction.

Design outcomes

Primary

MeasureTime frame
Aims to identify a cut off value which can accurately diagnose the presence of varices.Timepoint: 1 year

Secondary

MeasureTime frame
not applicableTimepoint: not applicable

Countries

India

Contacts

Public ContactDr Susan Dsouza

FATHER MULLER MEDICAL COLLEGE

susandsouza207@fathermuller.in09731923384

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026